$SCYYF

2024 Q4 Form 10-Q Financial Statement

#000143774924034770 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $90.54K
YoY Change -32.81%
Operating Profit
YoY Change
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$79.62K
YoY Change -206.54%
Net Earnings / Revenue
Basic Earnings Per Share $0.00
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 355.9M 355.9M
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $718.5K
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses $13.45K
Receivables
Other Receivables
Total Short-Term Assets $731.9K
YoY Change -36.67%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $715.2K
YoY Change 0.08%
TOTAL ASSETS
Total Short-Term Assets $731.9K
Total Long-Term Assets $715.2K
Total Assets $1.447M
YoY Change -22.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $254.2K
YoY Change -52.62%
SHAREHOLDERS EQUITY
Retained Earnings -$115.1M
YoY Change 0.32%
Common Stock $111.1M
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.193M
YoY Change
Total Liabilities & Shareholders Equity $1.447M
YoY Change -22.63%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$79.62K
YoY Change -206.54%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities
YoY Change
NET CHANGE
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change In Cash
YoY Change
FREE CASH FLOW
Cash From Operating Activities
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
CA
dei Entity Address City Or Town
EntityAddressCityOrTown
Reno
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89521
dei City Area Code
CityAreaCode
775
CY2023Q4 us-gaap Cash
Cash
1021956 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
40211 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1062167 usd
CY2023Q4 us-gaap Regulatory Assets Noncurrent
RegulatoryAssetsNoncurrent
11037 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
60782 usd
CY2024Q3 us-gaap Liabilities
Liabilities
254211 usd
CY2023Q4 us-gaap Liabilities
Liabilities
349259 usd
CY2023 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1777257 usd
us-gaap Net Income Loss
NetIncomeLoss
-235073 usd
us-gaap Net Income Loss
NetIncomeLoss
180976 usd
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Entity File Number
EntityFileNumber
000-54416
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1009717
CY2024Q3 us-gaap Cash
Cash
718474 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
13446 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
731920 usd
CY2024Q3 us-gaap Regulatory Assets Noncurrent
RegulatoryAssetsNoncurrent
11163 usd
dei Document Type
DocumentType
10-Q
us-gaap Net Income Loss
NetIncomeLoss
-235073 usd
us-gaap Net Income Loss
NetIncomeLoss
180976 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1093279 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21684 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-129756 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1248156 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10906 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1333794 usd
CY2024Q3 scy Exploration Expense Recovery
ExplorationExpenseRecovery
23981 usd
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
355860813
CY2023Q4 us-gaap Assets
Assets
1777257 usd
CY2024Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
49027 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
355860813
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
355860813
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
27882 usd
CY2024Q3 us-gaap General Insurance Expense
GeneralInsuranceExpense
7028 usd
CY2023Q3 us-gaap General Insurance Expense
GeneralInsuranceExpense
7921 usd
CY2024Q3 us-gaap Professional Fees
ProfessionalFees
7854 usd
CY2024Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
32903 usd
CY2023Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
52449 usd
CY2024Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
9409 usd
CY2023Q3 us-gaap Interest And Other Income
InterestAndOtherIncome
12348 usd
CY2024Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-6870 usd
CY2023Q3 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
164585 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-79620 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
74732 usd
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
355860813
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
355860813
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001408146
ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2024Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
0
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0
CY2024Q3 scy Common Stock Votes Per Share
CommonStockVotesPerShare
1 pure
dei Entity Registrant Name
EntityRegistrantName
SCANDIUM INTERNATIONAL MINING CORP.
dei Entity Address Address Line1
EntityAddressAddressLine1
2011 Phaeton Lane
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Local Phone Number
LocalPhoneNumber
355-9500
dei Security12b Title
Security12bTitle
None
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
CY2024Q3 us-gaap Assets
Assets
1447136 usd
us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
355860813
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
355860813
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
111144603 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
111144603 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1033333
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1033333
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1264194 usd
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1264194 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7306631 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7306631 usd
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-853400 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-853400 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-115140715 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-114905642 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1192925 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1427998 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1447136 usd
CY2023Q3 scy Exploration Expense Recovery
ExplorationExpenseRecovery
30653 usd
scy Exploration Expense Recovery
ExplorationExpenseRecovery
61616 usd
scy Exploration Expense Recovery
ExplorationExpenseRecovery
211779 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
18770 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
64296 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
74169 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
22697 usd
us-gaap General Insurance Expense
GeneralInsuranceExpense
23603 usd
CY2023Q3 us-gaap Professional Fees
ProfessionalFees
15844 usd
us-gaap Professional Fees
ProfessionalFees
81750 usd
us-gaap Professional Fees
ProfessionalFees
68239 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
98666 usd
us-gaap Labor And Related Expense
LaborAndRelatedExpense
183738 usd
CY2024Q3 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
0 usd
CY2023Q3 us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
0 usd
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
398 usd
us-gaap Travel And Entertainment Expense
TravelAndEntertainmentExpense
3737 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
90536 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
134749 usd
us-gaap Operating Expenses
OperatingExpenses
329423 usd
us-gaap Operating Expenses
OperatingExpenses
565265 usd
CY2024Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
8377 usd
CY2023Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
32548 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
36 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1952 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
24252 usd
us-gaap Interest And Other Income
InterestAndOtherIncome
30080 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
70062 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
714209 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
355860813
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
355860813
us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
59539 usd
scy Accruals Reversal
AccrualsReversal
0 usd
scy Accruals Reversal
AccrualsReversal
0 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
70062 usd
us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
714209 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
13446 usd
us-gaap Foreign Currency Transaction Gain Loss Unrealized
ForeignCurrencyTransactionGainLossUnrealized
2715 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-26765 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-12869 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-11666 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-254150 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-303482 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-717690 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-303482 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-717690 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1021956 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1852710 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
718474 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1135020 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
26949 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
236000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1356228 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
74732 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
227976 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-133772 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1427998 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-151196 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1276802 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-4257 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1272545 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-79620 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
1192925 usd
us-gaap Nature Of Operations
NatureOfOperations
<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody><tr style="vertical-align: top;"> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>1.</b></p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>NATURE AND CONTINUANCE OF OPERATIONS</b></p> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">Scandium International Mining Corp. (the “Company”) is a specialty metals and alloys company focusing on scandium and other specialty metals.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">The Company was incorporated under the laws of the Province of British Columbia, Canada in 2006. The Company currently trades on the Toronto Stock Exchange (TSX) under the symbol “SCY”.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">The Company’s focus is on the exploration and evaluation of its specialty metals assets, specifically the Nyngan scandium deposit located in New South Wales, Australia, The Company is an exploration stage company and anticipates incurring significant additional expenditures prior to production and any and all of its properties.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">These condensed interim consolidated financial statements have been prepared on a going concern basis that contemplates the realization of assets and discharge of liabilities at their carrying values in the normal course of business for the foreseeable future. These financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">The Company currently earns no operating revenues and will require additional capital in order to advance the Nyngan property. The Company’s ability to continue as a going concern is uncertain and is dependent upon the generation of profits from mineral properties, obtaining additional financing and maintaining continued support from its shareholders and creditors. These are material uncertainties that raise substantial doubt about the Company’s ability to continue as a going concern. In the event that additional financial support is not received, or operating profits are not generated, the carrying values of the Company’s assets may be adversely affected.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">The political upheavals in various countries have caused significant volatility in commodity prices. While these effects are expected to be temporary, the duration of the business disruptions internationally and related financial impact cannot be reasonably estimated at this time.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 54pt; text-align: justify;"><b>Use of estimates</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">The preparation of unaudited condensed interim consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to the deferred income tax asset valuations, asset impairment, stock-based compensation, derivative liabilities and loss contingencies. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between estimates and the actual results, future results of operations will be affected.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">The Company considers itself to be an exploration stage company and will consider the transition to development stage after it receives funding to begin mine construction, and board approval.</p>
CY2024Q3 us-gaap Mineral Properties Gross
MineralPropertiesGross
704053 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
34665000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.14
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
11400000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.035
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
6050000
CY2023 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.22
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
40015000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.1
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
3290000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0.15
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
36725000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.09
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
36725000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.09
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
36725000
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
36725000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
59539 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1033333
CY2024Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1264194 usd
CY2024Q3 us-gaap Mineral Rights
MineralRights
704053 usd
CY2024Q3 scy Property Plant And Equipment Net Including Mineral Rights Total
PropertyPlantAndEquipmentNetIncludingMineralRightsTotal
704053 usd
CY2023Q4 us-gaap Mineral Rights
MineralRights
704053 usd
CY2023Q4 scy Property Plant And Equipment Net Including Mineral Rights Total
PropertyPlantAndEquipmentNetIncludingMineralRightsTotal
704053 usd

Files In Submission

Name View Source Status
0001437749-24-034770-index-headers.html Edgar Link pending
0001437749-24-034770-index.html Edgar Link pending
0001437749-24-034770.txt Edgar Link pending
0001437749-24-034770-xbrl.zip Edgar Link pending
ex_745103.htm Edgar Link pending
ex_745104.htm Edgar Link pending
ex_745105.htm Edgar Link pending
ex_745106.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
image1.jpg Edgar Link pending
image2.jpg Edgar Link pending
image3.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
scy-20240930.xsd Edgar Link pending
scy20240930_10q.htm Edgar Link pending
Show.js Edgar Link pending
scy-20240930_cal.xml Edgar Link unprocessable
scy-20240930_lab.xml Edgar Link unprocessable
scy-20240930_pre.xml Edgar Link unprocessable
scy-20240930_def.xml Edgar Link unprocessable
scy20240930_10q_htm.xml Edgar Link completed